Switzerland - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Switzerland Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 3% year on year. In 2019, the country was ranked number 13 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate at 6.7 Days. South Korea topped the ranking with 15.9 Days in 2019, stable compared to 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico was the worst growing country at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.70 |
| 2018 | 6.80 |
| 2017 | 7.00 |
| 2016 | 6.90 |
| 2015 | 7.20 |
Download all data from 1975 to 2019
How does Switzerland rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 13 |
#13
Italy
|
6.70 | 2019 | -1.5 % | -2.0 % | View data | |
| 13 |
#13
Switzerland
|
6.70 | 2019 | -1.5 % | -3.0 % | View data | |
| 15 |
#15
Chile
|
6.60 | 2019 | -1.5 % | -0.9 % | View data | |